ADHD drugs' black-box warning sparks concern

02/15/2006 | USA Today

With the FDA's decision last week to add a black-box warning to Ritalin, Adderall and other attention deficit hyperactivity disorder medications, many parents may be thinking twice before putting their children on the medications. The decision was based on reports of 25 children and adults dying suddenly from 1999 to 2003 after taking the drugs.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX